{"name":"Hope Biosciences LLC","slug":"hope-biosciences-llc","ticker":"","exchange":"","domain":"hopellc.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Allogeneic HB-adMSCs","genericName":"Allogeneic HB-adMSCs","slug":"allogeneic-hb-admscs","indication":"Other","status":"phase_1"},{"name":"Autologous HB-adMSCs","genericName":"Autologous HB-adMSCs","slug":"autologous-hb-admscs","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Allogeneic HB-adMSCs","genericName":"Allogeneic HB-adMSCs","slug":"allogeneic-hb-admscs","phase":"phase_1","mechanism":"Adipose-derived mesenchymal stem cells that may modulate immune responses and promote tissue regeneration through paracrine signaling.","indications":[],"catalyst":""},{"name":"Autologous HB-adMSCs","genericName":"Autologous HB-adMSCs","slug":"autologous-hb-admscs","phase":"phase_2","mechanism":"Autologous adipose-derived mesenchymal stem cells that modulate immune responses and promote tissue regeneration through paracrine signaling.","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxOcTN2THdEMThXcVJtdEJNRy1laVBlVGd3QnJIOEp4M2U1NmpONWVubjBUZ21sNVVQUXFNenFKOFpTUUdFZk5vaG53RUhYamNXSUxrUU1KclBLT3pBU2NXZUNrU3c3TDhtcDlRUldGeW1ScE1ZTFltdFBJNkpmWFJUTTdCYVAweTdlRnJWaHF0ZVZ4QzBPVUQ0ZW5nR3AzRHNxZ1ZQbjVPd29hVkI4Q2ZXTkFBcHFIdWZG?oc=5","date":"2025-12-23","type":"trial","source":"Fierce Biotech","summary":"Hope springs toward Parkinson's phase 3 despite divergent stem cell therapy data - Fierce Biotech","headline":"Hope springs toward Parkinson's phase 3 despite divergent stem cell therapy data","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNMVBuam5LNDVJcXFaTzBUTkNELW42WnRzNzFYTm1ZOWNkSlUzWk8yeFYxaGNkdWJEcWZxQS04UDNXWDd4UmpJUXctM0tjRDB2VU9Yd3laemVocFFITUt4QjhmeTZTd2d1a21LSkU3NWFLOHBhMVJPZ2IxTWVZaGlWQlNmbm1oS1ZqLWJPVFpZWm9hYmR3X3hERDQ3ZEVwdm9FNGVuQnJZaEk0c01tWHFFZ0hCOXQzN1JwX3V1Qw?oc=5","date":"2025-10-10","type":"pipeline","source":"GeekWire","summary":"Between hype and hope: Seattle biotech leaders size up AI's real impact on drug development - GeekWire","headline":"Between hype and hope: Seattle biotech leaders size up AI's real impact on drug development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-gFBVV95cUxOaXQtYVUzV3JWWnhWT29WVUhJYS1sdVFvSG1jVU1YcUN2cVd5bmtTR2tHcy1oWWxScmRVN1FfVk8ycG9lTGc5NGxuOFloV3JQUnA1VWFVTzhGa3NnVGdKTW13ZXdwZ3poMmMwWXR0RG53amgxTjBzWW1Jc0tVSjVlLWM3akl5MWc0LU9JMWYxWTI1UnJVS0hlM1FtSHFMTndJbnI4NHNUMFZoNm54TVBONHZ4dmt0M0Q1eDVSaTlHNUZMeVU0RWkwV0pZeFVMRVEwcW1BZUhJcWpjeGVDOElGREN1ak80aWZmNm1jTk4wWDFHSDlFNjNiNWxB?oc=5","date":"2025-08-27","type":"regulatory","source":"businesswire.com","summary":"Hope Biosciences Secures FDA RMAT Designation for Stem Cell Therapy in Relapsing-Remitting Multiple Sclerosis - businesswire.com","headline":"Hope Biosciences Secures FDA RMAT Designation for Stem Cell Therapy in Relapsing-Remitting Multiple Sclerosis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gJBVV95cUxOS1k3aDdDWlpWTnRoT2JoUFl2M1FhYnk3SVdyTmdfYW5aVmpaSFU1S19XQ1ZlZjJDTkpNUVBLYXdGczNMQ3pyQmw4YjRlYnJnVDdKQlBKRlFsVkdEV0lISjh1dFBQNnJ5SXY5b1JVT3VhZ1R4Y3U4WGY2NVBTbk5fc1VsM0ZwMFU2R1g2NnhLcVFSQzVYYXZYX1gwcG5GamNJbUdKSDZLTXZ6TVNTSzN0ZkQwT0J5LU1rcmpJNEVwUVBRQ2h1dnc4bWtGVW9CWExWRm9uZHE0c19BTUpFbHpKY0plWEFhRTQtRklLZDZXaklGaHhtdFJwa1dwSDJ2Q0JuRVU3QkU0RUdxZEd1dl9xOGl4SmRLTHdHSXEyVW43czVZTU1QVTBGTGZ6S3haV3lmU21HQVZmQnNrTUs4MWZJTjhlOUhuekZTdzQybTY4aUJJSHU4SXNfV2J3cGQ5a2szcHc?oc=5","date":"2025-08-11","type":"pipeline","source":"BioSpace","summary":"HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Receipt of Final Clearance to Proceed to Closing of Dura Medical Acquisition from Florida's Agency for Health Care Administ","headline":"HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Receipt of Final Clearance to Proceed to Cl","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxQYnJaTnlfbnFibGJKdlBhVlM2cnVsWkFMRkZTdXl5aC1YdWl6X1VOSUFIMzY0RGttU09UWFVUOVZtS1pXVVV1ZFY4UFY5clF5aUFSblQ0OHduY1VEcmZmcEJhLS14UUl0NlNHaGxub3RBZ0x3ZXVaMG9GU0gxWWVfVE9ONzB6T2Nt?oc=5","date":"2025-05-15","type":"deal","source":"St. Louis Economic Development Partnership","summary":"Sentio BioSciences Builds Health and Hope in St. Louis - St. Louis Economic Development Partnership","headline":"Sentio BioSciences Builds Health and Hope in St. Louis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxQVlZnYjlDQXhCdDhXUnJVdEdGclV5YndPQ3FiTVFIOXVBVkI4NmxxblU1Q3lJcjZETnl3VHlsSU9uM3Nib2h3blZfRTdUZUZnaXREU1BhakRHQUZLbTV4RFJaNzJTVjJVMy10N18zdVA5bGtORHNydXlXTjFKdEFlYjNDWm44cVJFelk3VUhLNFVmV0VJblJuSm1QbTZpY1NnZDlsdk16U0NySDFZNXBmM09KYw?oc=5","date":"2025-05-06","type":"pipeline","source":"Fierce Pharma","summary":"Neurocrine holds on to branded tardive dyskinesia push with help from Wilson Phillips star - Fierce Pharma","headline":"Neurocrine holds on to branded tardive dyskinesia push with help from Wilson Phillips star","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxPVTRpYURfLTJ4U0taYTJNOWlhY0R0WmJ2TGYybDBtLUZJdnFOaEppRnktMjVhZ2Z2eHAyMHJmSk5MbmhhRm1ldGhycGstYndFczA0MWdwTWttUmFOWUxzY1RXcS1VaS12cXkwNHFHeWc2aUk3VmR6WkVJNVhLTTFSN1UxV2FYWWpVSXgwQXFiSGRnbnFOYmRpWHFGYlJ4X1lKYVlESmU4VXFKN1hJWUxJS1BHYlZuMGtpeHhCc3oyQUZUNmM3Q0MwdlNJOGFsbHFxekE?oc=5","date":"2025-03-05","type":"trial","source":"BioSpace","summary":"Hope Biosciences Launches Pioneering Stem Cell Trial for Pediatric Juvenile Idiopathic Arthritis - BioSpace","headline":"Hope Biosciences Launches Pioneering Stem Cell Trial for Pediatric Juvenile Idiopathic Arthritis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNRHhZR3lqbHFRMW96M0pXY3pVTS1YdEVGYTl5cWh0aml4VENCZjMxdUppVUVYSFJNYTd1ZWFxRGM3SkdaU0tjWWdCVDV1SkJFdTQwVkVDZVZLRW8yaXQtaXhwdlN4RlJhdDhhQnNKSk9YeGNuNzJvZEZHSzlvV2laNklRLU9jZ3pZTDJsSW1hMTRlSlVielk2TjdQZ1FzTEhhTGd3YU44bDNxZkpibjFlLXpidDRzc0laYVhn?oc=5","date":"2024-08-22","type":"pipeline","source":"Fierce Biotech","summary":"Novartis, Versant hope to repeat Chinook’s success by arming kidney biotech Borealis with $150M - Fierce Biotech","headline":"Novartis, Versant hope to repeat Chinook’s success by arming kidney biotech Borealis with $150M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxPVVlPRU0zRVdreXhhQzZzY20wVGRSSTB2UklpV1cxa2ZiYlBmM0VsLTIzQlRDUzlabUdiUlVEMF9BUTRxRUMxdlRpVWNtMGVJbnNCOGREcTZzVzJVY1d2MzdUNVJBd0pWRW5YMjBCU1VRd2dkUkMtcjF5TVUtUmtrVUFURTBvOXpVU3FRNG5OOTNJaXdPMFhqekN2cG9fNzM0eHE5NXBzZm5HOEY4a25QNzc5amRLTjVxbmE0eU5HcDIteVlkclM5d1lQSFVOYlRmMlZJdk1sWU1Wb1BwM01xdXhRMkdNTXptbjJJXzRMYzIwZUFPWnA5Rw?oc=5","date":"2022-05-02","type":"trial","source":"GlobeNewswire","summary":"Rancho Biosciences Launches the Single Cell Data Science Consortium With Four Charter Members - GlobeNewswire","headline":"Rancho Biosciences Launches the Single Cell Data Science Consortium With Four Charter Members","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":1,"phase_2":1},"enrichmentLevel":0,"visitCount":7,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}